Polyphor AG’s License Agreement With Fosun Pharma For Balixafortide In China

VISCHER advised Polyphor AG on all legal issues related to the transaction. Polyphor AG (SIX: POLN) and Shanghai Fosun Pharmaceutical (Group) Co. Ltd (“Fosun Pharma”, stock…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now